Buscopan Injectable Solution Patent Expiration

Exclusivity Information

Buscopan Injectable Solution holds 1 exclusivity out of which 1 has expired. Details of Buscopan Injectable Solution's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCE May 03, 2009

About Buscopan Injectable Solution

Buscopan Injectable Solution is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. Buscopan Injectable Solution uses N-Butylscopolammonium Bromide as the active ingredient.

Active Ingredient:

Buscopan Injectable Solution uses N-Butylscopolammonium Bromide as the active ingredient. Check out other Drugs and Companies using N-Butylscopolammonium Bromide ingredient.